Healthcare news

Featured image of article Recent clinical trials and high patenting activity on self-amplifying RNA announce new revolution in the field of mRNA vaccines.

Recent clinical trials and high patenting activity on self-amplifying RNA announce new revolution in the field of mRNA vaccines

Posted on by

SOPHIA ANTIPOLIS, France – November 29, 2022 │ KnowMade has identified high recent IP activity in the field of self-amplifying RNA vaccines. This activity could be the sign of an upcoming revolution in the RNA vaccine market. Self-amplifying RNA is a next-generation platform for mRNA vaccines Compared with traditional vaccines (live-attenuated, inactivated, recombinant etc.), effective[…]

Featured image of article Moderna vs Pfizer BioNTech - Let’s get inside the patent portfolio engaged in this battle.

Moderna vs Pfizer BioNTech – Let’s get inside the patent portfolio engaged in this battle

Posted on by

SOPHIA ANTIPOLIS, France – September 12, 2022 │ KnowMade recaps and details key patent information in Moderna’s lawsuit against Pfizer BioNTech, regarding the mRNA technology used in their COVID-19 vaccines. Patent infringement battles start Since the COVID-19 pandemic appears to be under control, companies developing mRNA are starting to enforce their IP rights. Among the[…]

Featured image of the article about CircRNA.

LARONDE, ORNA and THERORNA take the lead on circular mRNA therapeutic use

Posted on by

SOPHIA ANTIPOLIS, France – August 09, 2022 | KnowMade noticed recent patenting activity in the field of circular mRNA therapeutics, inspiring us to publish a brief statement about this therapeutic technology. What is a circular mRNA? CircRNA structure & function The first known circular RNA (CircRNA) function is a regulatory function (through miRNA regulation, transcription regulation,[…]

CureVac has acquired Frame Cancer Therapeutics with a promising patent portfolio on neoantigens for mRNA cancer vaccines

Posted on by

SOPHIA ANTIPOLIS, France – June 16, 2022 | CureVac N.V., a German biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), has announced on June 08th 2022 the acquisition of Frame Cancer Therapeutics (formerly Frame Pharmaceuticals), a startup company based in Netherlands focused on advanced genomics and bioinformatics to identify both unique and shared[…]